Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Apyx Medical Corp (APYX) is the subject of a Schedule 13G reporting group whose members may be deemed to beneficially own 2,280,518 shares, approximately 5.4% of outstanding shares, as of October 27, 2026. Philotimo Fund LP reported 1,425,473 shares and Philotimo Focused Growth & Income Fund reported 855,045. Kanen Wealth Management LLC reported the same 2,280,518 shares through its roles as general partner and investment manager, and David L. Kanen may be deemed to beneficially own those shares through his role as managing member. These figures reflect the same fund-held shares, not additional holdings.
Key Figures
Philotimo Fund LP beneficial ownership:1,425,473 sharesPhilotimo Fund LP ownership percentage:3.4%Philotimo Focused Growth & Income Fund beneficial ownership:855,045 shares+4 more
7 metrics
Philotimo Fund LP beneficial ownership1,425,473 sharesAs of the close of business on October 27, 2026
Philotimo Fund LP ownership percentage3.4%As of the close of business on October 27, 2026
Philotimo Focused Growth & Income Fund beneficial ownership855,045 sharesAs of the close of business on October 27, 2026
Philotimo Focused Growth & Income Fund ownership percentage2.0%As of the close of business on October 27, 2026
Reporting group beneficial ownership2,280,518 sharesAs of the close of business on October 27, 2026
Reporting group ownership percentage5.4%As of the close of business on October 27, 2026
Shares outstanding42,124,023 sharesAs of August 5, 2026; basis for reported ownership percentages
Key Terms
beneficially own, Shared Voting Power, Shared Dispositive Power, group
4 terms
beneficially ownregulatory
"may be deemed to beneficially own the shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Powerregulatory
"Shared Voting Power 2,280,518.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 2,280,518.00"
groupregulatory
"Each Reporting Person is a member of a "group""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many APYX shares did the reporting group beneficially own?
The reporting group may be deemed to beneficially own 2,280,518 APYX shares, approximately 5.4% of outstanding shares, as of October 27, 2026. The reported amount reflects 1,425,473 shares held by Philotimo Fund LP and 855,045 held by Philotimo Focused Growth & Income Fund.
Who has voting and dispositive power over the reported APYX shares?
The cover-page figures report shared voting and shared dispositive power over 1,425,473 shares for Philotimo Fund LP and 855,045 shares for Philotimo Focused Growth & Income Fund. Kanen Wealth Management LLC and David L. Kanen each report shared voting and dispositive power over 2,280,518 shares through the fund holdings.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Apyx Medical Corp
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
03837C106
(CUSIP Number)
10/21/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
03837C106
1
Names of Reporting Persons
Philotimo Fund, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,425,473.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,425,473.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,425,473.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.4 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
03837C106
1
Names of Reporting Persons
Philotimo Focused Growth & Income Fund
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
855,045.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
855,045.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
855,045.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
03837C106
1
Names of Reporting Persons
Kanen Wealth Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FLORIDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,280,518.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,280,518.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,280,518.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
03837C106
1
Names of Reporting Persons
Kanen David
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,280,518.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,280,518.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,280,518.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Apyx Medical Corp
(b)
Address of issuer's principal executive offices:
5115 ULMERTON ROAD, CLEARWATER, FLORIDA, 33760.
Item 2.
(a)
Name of person filing:
This statement is filed by Philotimo Fund LP, a Delaware limited partnership (Philotimo), Philotimo Focused Growth & Income Fund, a series of World Funds Trust, a Delaware statutory trust (PHLOX), Kanen Wealth Management, LLC, a Florida limited liability company (KWM), and David L. Kanen. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
KWM is the general partner of Philotimo and the investment manager of PHLOX. Mr. Kanen serves as the managing member of KWM. By virtue of these relationships, KWM and Mr. Kanen may be deemed to beneficially own the shares of Common Stock, $0.001 par value per share, of Apyx Medical Corp held by Philotimo and PHLOX.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of Philotimo, KWM, PHLOX and Mr. Kanen is 6810 Lyons Technology Circle, Suite 160, Coconut Creek, FL 33073.
(c)
Citizenship:
Philotimo is organized under the laws of the State of Delaware. PHLOX is a series of World Funds Trust, a statutory trust organized under the laws of the State of Delaware. KWM is organized under the laws of the State of Florida. Mr. Kanen is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP Number(s):
03837C106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on October 27, 2026:
(i) Philotimo beneficially owned 1,425,473 Shares;
(ii) PHLOX beneficially owned 855,045 Shares;
(iii) KWM beneficially owned 2,280,518 Shares, consisting of (a) the 1,425,473 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 855,045 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX;
(iv) Mr. Kanen may be deemed to beneficially own 2,280,518 Shares through his position as managing member of KWM, consisting of 1,425,473 Shares held by Philotimo and 855,045 Shares held by PHLOX.
Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 2,280,518 Shares beneficially owned in the aggregate by all the Reporting Persons, constituting approximately 5.4% of the outstanding Shares. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.
(b)
Percent of class:
The aggregate percentage of the Shares reported owned by each person named herein is based upon 42,124,023 Shares outstanding as of August 5, 2026, which is the total number of Shares outstanding as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.
As of the close of business on October 27, 2026:
(i) Philotimo beneficially owned approximately 3.4% of the outstanding Shares;
(ii) PHLOX beneficially owned approximately 2.0% of the outstanding Shares;
(iii) KWM beneficially owned approximately 5.4% of the outstanding Shares; and
(iv) Mr. Kanen beneficially owned approximately 5.4% of the outstanding Shares.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit 99.1.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Philotimo Fund, LP
Signature:
/s/ David L. Kanen
Name/Title:
David L. Kanen, Managing Member of Kanen Wealth Management LLC, its general partner
Date:
10/28/2026
Philotimo Focused Growth & Income Fund
Signature:
/s/ David L. Kanen
Name/Title:
David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment manager
